Global Immuno-Oncology Assay Market Growth, Size & Forecast 2025-2030

The Global Immuno-Oncology Assay Market size was valued at around USD 3.62 billion in 2024 and is projected to reach USD 6.86 billion by 2030. Along with this, the market is estimated to grow at a CAGR of around 11.25% during the forecast period, i.e., 2025-30.                  

Global Immuno-Oncology Assay Market Driver:

Rising Cancer Cases Globally to Drive Immuno-Oncology Assay – The substantial growth in the Global Immuno-Oncology Assay Market has been attributed to the increasing prevalence of cancer globally. The global incidence of cancer has risen significantly, with notable increases reported in countries such as the US and India, as documented by leading healthcare organizations like the World Health Organization, the International Agency for Research on Cancer, and the Global Cancer Observatory.

This surge in cancer cases has underscored the imperative for effective management. Consequently, countries, particularly the United States and India, have implemented measures to combat cancer, leading to heightened awareness among patients. This heightened awareness has driven the need for immune-oncology assays globally, catering to the need for early-stage detection and diagnosis.

Furthermore, global cancer research and healthcare organizations predict a continued increase in cancer cases in the years ahead. This prediction is based on factors such as the proliferation of carcinogenic pollutants in the environment and the growing prevalence of genetic mutations as significant contributors to cancer development. As a result, the demand for better immune-oncology diagnostic services would amplify in the coming years as well.

Download a free sample copy of the Report: https://www.marknteladvisors.com/query/request-sample/immuno-oncology-assay-market.html

Market Dimensions & Projections

·        Pricing Evaluation

·        Recent Strategic Moves by Companies

·        Primary Stakeholders

·        Import/Export Trend Analysis

·        Competitive Landscape Assessment

·        Emerging Opportunities

·        Market Trends and Indicators

 

*Reports Delivery Format - Market research studies from MarkNtel Advisors are offered in PDF, Excel and PowerPoint formats. Within 24 hours of the payment being successfully received, the report will be sent to your email address.

Browse Full Report including (TOC+ List of Table and Figures): https://www.marknteladvisors.com/research-library/immuno-oncology-assay-market.html

Global Immuno-Oncology Assay Market Segmentation:

The market report categorizes the market based on different segments and geographical analysis.

Study Timeline:

-Base Year: 2024

-Historical Period: 2020 to 2023

-Forecast Period: 2025 to 2030

  • By Product & Services
    • Reagents and Antibodies- Market Size & Forecast 2020-2030F, USD Million
    • Testing Kits- Market Size & Forecast 2020-2030F, USD Million
    • Instruments- Market Size & Forecast 2020-2030F, USD Million
    • Consumables & Accessories- Market Size & Forecast 2020-2030F, USD Million
    • Software- Market Size & Forecast 2020-2030F, USD Million
  • By Assay Type
    • Checkpoint Inhibitor Assays- Market Size & Forecast 2020-2030F, USD Million
    • Cytokine Profiling Assays- Market Size & Forecast 2020-2030F, USD Million
    • Protein Biomarker Assays- Market Size & Forecast 2020-2030F, USD Million
    • Genomic Sequencing and Mutational Analysis- Market Size & Forecast 2020-2030F, USD Million
    • Immune Profiling Assays- Market Size & Forecast 2020-2030F, USD Million
    • Tumour Biomarker Assays-  Market Size & Forecast 2020-2030F, USD Million
    • Others (Gene Expression Profiling Assays, Multiplex Assays, etc.)- Market Size & Forecast 2020-2030F, USD Million
  • By Technology
    • Polymerase Chain Reaction- Market Size & Forecast 2020-2030F, USD Million
    • Immunoassay- Market Size & Forecast 2020-2030F, USD Million
    • Next-generation Sequencing- Market Size & Forecast 2020-2030F, USD Million
    • In-situ Hybridization- Market Size & Forecast 2020-2030F, USD Million
    • Flow Cytometry- Market Size & Forecast 2020-2030F, USD Million
    • Others (Mass Spectrometry, Immunohistochemistry (IHC), etc.) - Market Size & Forecast 2020-2030F, USD Million
  • By Indication
    • Lung Cancer- Market Size & Forecast 2020-2030F, USD Million
    • Breast Cancer- Market Size & Forecast 2020-2030F, USD Million
    • Colorectal Cancer- Market Size & Forecast 2020-2030F, USD Million
    • Prostate Cancer- Market Size & Forecast 2020-2030F, USD Million
    • Ovarian Cancer- Market Size & Forecast 2020-2030F, USD Million
    • Others (Bladder Cancer, Melanoma, etc.)- Market Size & Forecast 2020-2030F, USD Million
  • By Application
    • Clinical Assay- Market Size & Forecast 2020-2030F, USD Million
    • Research & Development- Market Size & Forecast 2020-2030F, USD Million
  • By End User
    • Hospitals- Market Size & Forecast 2020-2030F, USD Million
    • Cancer Research Centers- Market Size & Forecast 2020-2030F, USD Million
    • Specialty Cancer Clinics- Market Size & Forecast 2020-2030F, USD Million
    • Clinical Laboratories- Market Size & Forecast 2020-2030F, USD Million
    • Others (Contract Research Organizations (CROs), Contract Development & Manufacturing Organizations (CDMOs), etc.) - Market Size & Forecast 2020-2030F, USD Million
  • By Region
    • North America
    • South America
    • Europe
    • Middle East & Africa
    • Asia-Pacific

 

Competitive Landscape

With strategic initiatives, such as mergers, collaborations, and acquisitions, the leading market companies, including -   Agilent Technologies Inc., Aviva Systems Biology Corporation, PerkinElmer Inc., Bio-Rad Laboratories, Inc., Illumina Inc., Qiagen N.V, Thermo Fisher Scientific, Inc., Sartorius AG, NanoString Technologies, Inc., BioGenex, Abbott Laboratories, Inc., Asuragen Inc., Meso Scale Assay, LLC, Merck Millipore, Enzo Biochem Inc., and Others.

Have questions? Our consultant is ready to assist: https://www.marknteladvisors.com/query/request-customization/immuno-oncology-assay-

market.htmlWe follow a tried-and-tested research methodology that blends top-down and bottom-up approaches to deliver highly accurate market insights. Every report is powered by data triangulation, ensuring well-rounded and validated findings.

From smart sample selection and reliable data collection to in-depth analysis and precise forecasting, our process is designed to minimize error and maximize impact.

About Us –

MarkNtel Advisors is a leading consulting, data analytics, and market research firm that provides an extensive range of strategic reports on diverse industry verticals. We being a qualitative & quantitative research company, strive to deliver data to a substantial & varied client base, including multinational corporations, financial institutions, governments, and individuals, among others.

We have our existence across the market for many years and have conducted multi-industry research across 80+ countries, spreading our reach across numerous regions like America, Asia-Pacific, Europe, the Middle East & Africa, etc., and many countries across the regional scale, namely, the US, India, the Netherlands, Saudi Arabia, the UAE, Brazil, and several others.

Contact Us

MarkNtel Advisors

Email: sales@marknteladvisors.com

Website: www.marknteladvisors.com

Latest Press Release - https://www.marknteladvisors.com/press-release

إقرأ المزيد